Afya 2026 Outlook | Profits, Share Price & Analysis

Afya

NasdaqGS:AFYA

$ 14,06

+ $0,06 (0,43%)

14,06 $

+$0,06 (0,43%)

End-of-day quote: 05/26/2026

Afya Stock Value

Analysts currently see Afya at the level of Underperform.

Underperform

Afya Company Info

EPS Growth 5Y

18,25%

Market Cap

$1,25 B

Long-Term Debt

$0,36 B

Quarterly earnings

08/26/2026

Dividend

$0,69

Dividend Yield

4,92%

Founded

1999

Industry

Health Care

Country

Brazil

Website

Afya

ISIN Number

KYG011251066

Website

http://www.afya.com.br

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

$16,46

17.07%

Last Update: 05/20/2026

Analysts: 9

Highest Price Target $21,27

Average Price Target $16,46

Lowest Price Target $14,70

In the last five quarters, Afya’s Price Target has fallen from $27,85 to $19,59 - a -29,66% decrease. One analysts predict that Afya’s share price will increase in the coming year, reaching $16,46. This would represent an increase of 17,07%.

Top growth stocks in the health care sector (5Y.)

What does Afya do?

Afya Limited operates as a medical education group in Brazil. The company is delivering an end-to-end physician-centric ecosystem that serves and empowers students to be lifelong medical learners from the moment they join it as medical students through their medical residency preparation, graduation program, medical post-graduate specialization programs and continuing medical education activities, or CME, including through digital health services. The company’s innovative methodological approac...

The company’s innovative methodological approach combines integrated content, interactive learning, and an adaptive experience for lifelong medical learners. Through its educational content and technology-enabled activities, the company focuses on effective, personalized learning that mirrors one-on-one tutoring.

The company’s undergraduate and graduate campuses are spread across 19 Brazilian states, and its digital medical platform is available across Brazil. As of December 31, 2023, the company’s network of 47 undergraduate and graduate medical school campuses consisted of 32 undergrad operating units (i.e., units that have been approved by MEC and that have commenced operations) and one approved unit (i.e., a unit that have been approved by MEC but that have not yet commenced operations). As of December 31, 2023, the company’s network of 3,163 medical school seats consisted of 3,113 operating seats (seats that have been approved by MEC and that have commenced operations) and 50 approved seats (seats that have been approved by MEC but that have not yet commenced operations).

The company offers residency preparatory courses and medical postgraduate specialization programs, delivering printed and digital content, an online medical education platform and practical medical training.

The acquisition of PEBMED, MedPhone, iClinic, Medicinae, Medical Harbour, Cliquefarma, Shosp, RX PRO, Além da Medicina, CardioPapers and Glic marked the company’s evolution in the digital health services sector, complementing its end-to-end offering to healthcare professionals.

Through PEBMED, the company acquired three different products: Whitebook, a mobile and web application that assists doctors and medical professionals in clinical daily decision-making; Nursebook, a mobile application that assists nurses in clinical decision-making; Portal PEBMED, a website that offers free content, including opinions, papers and updates in connection with medical news and scientific publications. PEBMED has more than 200,000 monthly active users on the Whitebook platform and approximately 500,000 monthly active users to Portal PEBMED. The acquisition expanded the company’s products and services offerings and offers significant cross-sell and upsell opportunities.

iClinic is a SaaS model physician focused technology company and one of the leading medical practice management software in Brazil. They seek to empower doctors to be more independent and have more control over their careers by digitalizing their daily routine, so they can increase their productivity and deliver better healthcare services. Their portfolio includes: Electronic Medical Record: the first electronic medical record as a SaaS model in Brazil focused on the physician experience; Clinical Management System: with this software doctors can schedule patients online, organize their financial records, use marketing tools to promote their clinics and others; Telemedicine: a platform to provide online consultations fully integrated with doctor’s schedule and records; and Physicians Marketplace: a website that connects doctors and patients to schedule consultations. As of December 31, 2023, the software had almost 26,263 users. The platform is used for almost 23 million medical consultations per year, of which around 151,503 were through telemedicine and prescribed more than 7,649,132 electronic medical prescriptions.

Medicinae is a healthcare technology company specializing in healthcare payments and financial services. It offers a financial platform that allows healthcare professionals to manage receivables in an efficient and scalable way using FIDC (receivables investment fund).

Medical Harbour offers educational health and medical imaging solutions through an interactive platform for anatomical study, 3D virtual dissection and analysis of medical images, which allow the exploration, and knowledge of human anatomy with digital resources: educational health solutions: Athena Hub specialized in anatomy was created to support dynamic teaching and allow physicians, teachers and students to interact and manipulate a real human body on a digital platform. Considering the high prices, restriction policies and difficulty on maintaining a human body for anatomy classes, Athena Hub allows students to interact with a digital human body instead of the aged and degenerate bodies for educational purposes. The solution count with virtual body, anatomy modules, and real exam analysis with photorealistic rendering. And (ii) medical imaging solutions: Athena DICOM and MH Cloud specialized in medical imaging with a range of products that simplifies radiology and teleradiology. Allow physicians to visualize, manipulate, share and store medical imaging with the certification of ANVISA (Brazilian Health Agency).

Cliquefarma is a healthtech company operating a free-to-use website that tracks prescription drugs, cosmetics and personal hygiene product prices in Brazil. Users of Cliquefarma can search for medications or healthcare products and compare prices from over 5,661 pharmacies in Brazil. The traffic generated is monetized through a cost-per-click model, where drugstores pay for each click on their ads, and a cost-per-acquisition model, where drugstores pay for each concluded sale. In 2023, Cliquefarma generated traffic of 15.2 million visitors.

Shosp is a clinical management software that offers all functionalities needed for clinics all over Brazil to manage their financials, patients’ appointments, medical records, marketing, and others. The acquisition of Shosp reinforces the digital prescription digital pillar and creates synergies with iClinic and Medicinae solutions.

RX PRO is a digital platform that connects physicians with the pharmaceutical industry, providing specialized and personalized marketing for those companies, in a more convenient way for physicians. RX PRO has already delivered free samples to more than 62,000 physicians with an innovative digital experience, with a Net Promoter Score, or NPS, of 76.9 and as of the date of this annual report has 10 pharmaceutical companies using its platform. RX PRO is monetized by providing a B2B subscription service to the pharmaceutical industry.

Além da Medicina is an online medical content platform for physicians and medical students that provides educational tools and technical medical content to assist them throughout their careers. Its robust content includes mentoring for residency, soft skills, finance, accounting, and investment basics for physicians. Além da Medicina had more than 7,000 subscribers as of December 31, 2023, and more than 125,000 followers on Instagram.

CardioPapers is the main medical content and education platform in the Cardiology field, offering courses and books developed by physicians and for physicians, covering all phases of the medical career, aligned with the company’s overall business strategy. CardioPapers had 8,535 students in 2023 and almost 285,000 followers on Instagram. The platform includes more than ten courses, such as a cardiology specialist degree preparatory course, cardiological emergencies course, preoperative course, dyslipidemia course, electrocardiogram (EKG) course and diabetes course, exploring the cardiologic medical field and also expanding to other medical areas.

Glic is a free diabetes care and management app solution for physicians and patients that uses technology to improve diabetes education and daily routine practices, connecting users, devices and healthcare providers.

The company offers residency preparatory courses and medical post-graduate specialization programs, delivering printed and digital content, an online medical education platform and practical medical training. As of December 31, 2023, the company had 66,034 enrolled students.

Growth Strategies

The key elements of the company’s strategy are to maturation of current number of authorized medical school seats; open new campuses in connection with the Mais Médicos program; expand its medical residency preparation enrollments base; expand its graduate programs enrollments base; cross-sell across its existing medical student base; expand its B2B capabilities; expand its distribution channels; leverage infrastructure and extract synergies from acquisitions; continue to selectively pursue M&A opportunities; enter into new markets; and develop new products.

Geographic Presence

The company’s content creation and dedicated sales team is located in São Paulo, in the state of São Paulo.

Products and Services

The company offers the following educational products and services to lifelong medical learners enrolled across its evolving distribution network, as well as to third-party medical schools.

Medical Schools

A fully integrated core curriculum is offered to the company’s medical school students across all its campuses.

All its medical students have access to the company’s supplemental instructional platforms as part of the internship module of their medical course, which it implemented for all incoming medical students of the fifth and sixth academic year.

Medical Residency Preparatory Courses

Instructional content in digital format is offered to medical students and newly graduated physicians to prepare them for medical residency exams. Supplementary instructional content in digital format is offered to third-party medical schools that adopt the company’s services. As of December 31, 2023, the company had 7,563 enrolled students in its medical residency preparatory courses.

Graduate Courses

Graduate medical courses are offered to the company’s medical school students across all its campuses. These students also have access to some of the company’s supplemental instructional platforms. Supplemental instructional content for different medical specializations is offered to individual lifelong medical learners in the company’s graduate courses.

Other Programs

Other national core curriculum is offered to all students across all of the company’s undergraduate campuses: healthcare degrees and a subset of non-healthcare degrees, including business and engineering degrees offered by the companies it invested in or acquired.

Digital Health Services

Subscription-based mobile app and website portal focused on assisting health professionals and students with clinical decision-making for 30 medical specializations through tools such as medical calculators, charts and updated content, including prescriptions, clinical scores, medical procedures and laboratory exams, among others. Free instructional content the company offers to physicians, healthcare professionals and students.

Lifelong Medical Learner Clients

In addition to health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition and biomedicine, the company offers degree programs and courses in other non-health sciences subjects and disciplines across several of its campuses, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering and pedagogy. These non-health sciences courses are not part of its core business—the number the company offers has increased as a consequence of its strategic acquisitions in recent years of multi-disciplinary schools with strong health sciences programs, which are its principal focus. Although non-health courses are not part of its growth strategy, the company expects to continue to offer them to the extent they generate local demand.

In addition, as of December 31, 2023, the company had 17 contracts with other partner companies, which represents its B2B segment.

Student Financing and Incentive Programs

Student financing program—Fundo de Financiamento Estudantil (FIES)

FIES is a MEC program created by Law No. 10,260/2001 to provide financing to undergraduate students who are unable to finance their own education. After going through several reforms from 2015 onwards, as of December 31, 2023, the FIES program is provided in the following categories:

Public FIES (2018)—Extended to persons with a per capita income of up to three minimum wages, with zero interest rate, with the credit risk being divided between the government and the private Higher Education Institutions, or HEIs;

Private FIES (2018)—Extended to persons with a per capital income of up to five minimum wages, with low interest rates. Regional funds and private financial institutions, provide the financing; and

Social FIES (2024)—Reserves at least 50% of FIES vacancies in each selection process for students with a per capita family income of up to half a minimum wage, with zero interest rate.

Seasonality of Operations

The company has three reporting segments: Undergrad, which provides educational services through undergraduate courses related to medicine, other health sciences and other undergraduate programs; Continuing Education, which provides specialization programs and graduate courses; and Digital Services, which provides content and technology for medical education, clinical decisions software, practice management tools and electronic medical records, doctor-patient relationship, telemedicine and digital prescription.

Digital Services consists mainly of Pebmed, Medcel, and iClinic revenues. While Pebmed and iClinic generally do not experience significant fluctuations resulting from seasonality, Medcel’s revenue is concentrated in the first and last quarter of the fiscal year due to the period of enrollments of Medcel’s clients. In addition, the majority of Medcel’s revenues are derived from printed books and e-books, which are recognized at the point in time when control is transferred to the customer. Consequently, the Digital Services segment generally has higher revenues and results of operations in the first and last quarters of the fiscal year than in the second and third quarters of the fiscal year (year ended December 31, 2023).

Marketing and Sales

The company’s marketing and sales efforts are supported by Insider, Braze and Active Campaign, as well as other online analytical tools, such as Hubspot and Salesforce products (Sales Cloud, Marketing Cloud and Einstein).

Intellectual Property

As of December 31, 2023, the company owned 375 trademark registrations in Brazil, and it had also sought to register trademarks abroad, in the United States, in the European Union, Portugal, Mexico and Colombia. As of December 31, 2023, the company had 169 pending trademark applications in Brazil and unregistered trademarks that it uses to promote its brand, and also owned 344 registered domain names in Brazil and 21 registered international domain names, and have registered two software in Brazil.

History

Afya Limited was founded in 1999. The company was incorporated in 2019.

Afya Questions and Answers

Which sectors generate sales and which are the top 3 markets?

**revenue distribution by sectors:** - education: approx. 70% - digital health services: approx. 30% **top 3 markets and their percentage shares:** - brazil: approx. 85% - argentina: approx. 10% - chile: approx. 5% afya limited generates the majority of its revenue from the education sector, parti...

At which locations are the company’s products manufactured?

**production sites:** brazil afya limited is a leading company in the field of medical education in brazil. the company does not produce physical products in the traditional sense, but offers educational services and digital solutions for medical students and professionals. afya limited's main...

What strategy does Afya pursue for future growth?

**revenue growth:** estimated at 10-12% (2026, based on historical data and market trends) afya limited is pursuing a growth strategy that heavily focuses on expanding its digital educational offerings and integrating new technologies into its existing platforms. the company has significantly inves...

Which raw materials are imported and from which countries?

**commodities/materials:** educational software, medical equipment **countries of origin:** usa, germany, china afya limited is a leading company in the education sector specializing in medical training. the company mainly imports educational software and medical equipment necessary for the operat...

How strong is the company’s competitive advantage?

**market share:** estimated at 25% in the brazilian education sector (2026) **ebitda margin:** 35% (2025) afya limited has a significant competitive advantage in the brazilian education sector, especially in the field of medical education. the company benefits from strong brand recognition and an...

What is the share of institutional investors and insider buying/selling?

**institutional investor share:** 65% (estimated, 2026) **insider buys/sells:** no significant transactions in the last year (estimated, 2026) the institutional investor share in afya limited is estimated to be around 65%. this demonstrates a strong confidence from institutional investors in the...

What percentage market share does Afya have?

**market share of afya limited:** 18% (estimated for 2026) **top competitors and their market shares:** 1. **kroton educacional s.a.:** 25% 2. **yduqs participações s.a.:** 22% 3. **ser educacional s.a.:** 15% 4. **cogna educação s.a.:** 12% 5. **anima holding s.a.:** 8% **moat of afya limited:**...

Is Afya stock currently a good investment?

**revenue growth:** 10% (2025) **profit growth:** 8% (2025) **market share in the education sector brazil:** 20% (2025) afya limited recorded a revenue growth of 10% in 2025, indicating sustained demand for medical education and services in brazil. the company has further strengthened its posit...

Does Afya pay a dividend – and how reliable is the payout?

**dividend payment:** no dividend (as of 2026) afya limited has not paid any dividends so far. the company is strongly focused on growth and reinvesting in its educational and healthcare services in brazil. afya limited's strategy emphasizes expanding and increasing its market presence, which...

New support ticket

Explore

Afya Stock Value

Afya Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Afya do?

Afya Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

Afya Stock Value

Afya Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Afya do?

Afya Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.